Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-050339
Filing Date
2008-03-07
Accepted
2008-03-07 17:21:31
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 951248
2 SUMMARY OF 2008 BONUS TARGETS dex107.htm EX-10.7 3978
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3758
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9731
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9946
6 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3135
7 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3137
9 GRAPHIC g46728g39k97.jpg GRAPHIC 56659
10 GRAPHIC g46728g96y73.jpg GRAPHIC 43159
11 GRAPHIC g46728img001.jpg GRAPHIC 7558
12 GRAPHIC g46728img002.jpg GRAPHIC 12372
  Complete submission text file 0001193125-08-050339.txt   1151807
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50676 | Film No.: 08675159
SIC: 2834 Pharmaceutical Preparations